"Prescribing" Exercise to Cancer Patients At High-Risk for Falls

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-03

Study Completion Date

2024-08-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurious falls.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients

NCT07044427

Multiple Myeloma Fall Risk Factors Strength Training Effects +1 more

RECRUITING NA

Optimizing Fall-risk Prediction in Older Adults With Cancer

NCT02912273

Cancer

COMPLETED

Sarcopenia and Risk of Falls in Patients With Major Chronic Diseases

NCT03798418

Stroke Osteoporosis Chronic Kidney Diseases +1 more

COMPLETED NA

Fall Recovery Training for Older Adults in Continuous Care Facilities

NCT02173015

Accidental Falls

COMPLETED NA

The Effects of a 6-week Balance, Agility, Strengthening Exercise Class

NCT04318574

Neoplasms

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The investigator will incrementally increase the exercise prescription for groups of patients.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pedometer

Participants will wear a pedometer for 4 days at baseline, and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Intervention Type OTHER

Actigraph

Participants will wear a Actigraph for 4 days at baseline and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Intervention Type OTHER

Perturbation Treadmill

Participants will walk on an instrumented treadmill while wearing a safety harness at baseline and 4-6 weeks later. The perturbation treadmill will assess an individual's risk for falling. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any cancer diagnosis, as documented in medical record, other than non-melanoma skin cancer.
* No issues such as unstable angina or loss of a limb that would preclude exercise.

Exclusion Criteria

* Diagnosis of non-melanoma skin cancer
* Unstable angina
* Loss of limb, which limits exercise capabilities at the discretion of the Principal Investigators
* Pregnant women

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No